Anti-ML-IAP/BIRC7 Antibody

Raised in rabbit against the melanoma inhibitor of apoptosis protein (ML-IAP), this polyclonal reagent targets the BIRC7 antigen that researchers study for its role in regulating cell survival pathways. Distributed by Antibodies.com, the antibody cross-reacts with both human and mouse samples, enabling comparative IAP-family studies across species in apoptosis, oncology, and tumor-biology research.

The reagent is supplied as 100 µl of a 1 mg/ml stock in PBS buffered with 0.1% sodium azide and 50% glycerol, ready to dilute into common western blot, immunohistochemistry, and immunofluorescence workflows. Conjugated to no reporter, the immunoglobulin accepts downstream labeling with HRP, biotin, fluorophore, or alkaline phosphatase chemistries chosen by the end user, accommodating both chromogenic and fluorescence-based detection of BIRC7 expression in cultured cells, formalin-fixed tumor sections, and tissue microarray preparations.